JP5953873B2 - Method for producing biomolecule printed matter - Google Patents
Method for producing biomolecule printed matter Download PDFInfo
- Publication number
- JP5953873B2 JP5953873B2 JP2012075484A JP2012075484A JP5953873B2 JP 5953873 B2 JP5953873 B2 JP 5953873B2 JP 2012075484 A JP2012075484 A JP 2012075484A JP 2012075484 A JP2012075484 A JP 2012075484A JP 5953873 B2 JP5953873 B2 JP 5953873B2
- Authority
- JP
- Japan
- Prior art keywords
- biomolecule
- layer
- ink
- printing
- printed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Credit Cards Or The Like (AREA)
- Printing Methods (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
Description
本発明は、生体分子インキ印刷物の製造方法に関し、さらに詳しくは、製造工程中に擦れたり、郵送中やエンドユーザーでの取り扱いなどにより擦れたり、削れたり、かきとられたりせず、生体分子インキ印刷物に生体分子が残存して容易に生体分子を検出することのできる生体分子インキ印刷物の製造方法に関するものである。
The present invention relates to a method for producing a biomolecule ink print, and more particularly, the biomolecule ink is not rubbed during the production process, rubbed, scraped or scraped during mailing or handling by an end user. a method for producing a biomolecule ink printing material that can be biomolecules printed matter is detected easily biomolecules remain.
本明細書において、配合を示す「比」、「部」、「％」などは特に断わらない限り質量基準であり、「／」印は一体的に積層されていることを示す。また、「ＵＶ」は「紫外線」の略語、機能的表現、通称、又は業界用語である。 In the present specification, “ratio”, “part”, “%” and the like indicating the composition are based on mass unless otherwise specified, and the “/” mark indicates that they are integrally laminated. “UV” is an abbreviation, functional expression, common name, or industry term for “ultraviolet light”.
（背景技術）生体分子インキ印刷物は生体分子を含有しているインキを用いて、印刷された印刷物であるが、製造工程中に擦れたり、郵送中やエンドユーザーでの取り扱いなどにより生体分子インキ印刷物の生体分子印刷層であるインキ層が擦れたり、削れたり、かきとられたりする恐れがある、その結果、生体分子が減少又は無くなって、生体分子を検出できず、効果がなくなってしまうというデメリットがあった。また、生体分子を含有しているインキを基材に直接印刷すると、インキが基材に染み込んだり、印刷後でも生体分子が基材へ移行したり、生体分子が減少又は消失する恐れがある。すると、生体分子を増量したり、基材も含めた破壊検査をしないと含有している生体分子を確認できない、というデメリットもあった。 (Background Art) Biomolecule ink printed matter is a printed matter using ink containing biomolecules, but it is rubbed during the manufacturing process, or printed by biomolecule ink due to mailing or handling by end users. There is a risk that the ink layer, which is the biomolecule printing layer, may be rubbed, scraped, or scratched, resulting in a decrease or disappearance of the biomolecules, the inability to detect biomolecules, and loss of effectiveness. was there. In addition, when ink containing a biomolecule is directly printed on a substrate, the ink may soak into the substrate, the biomolecule may migrate to the substrate even after printing, or the biomolecule may decrease or disappear. Then, there was a demerit that biomolecules contained cannot be confirmed unless the amount of biomolecules is increased or a destructive inspection including the base material is performed.
（従来技術）従来、吸着チップであって、該吸着チップは、以下：（ａ）表面を含む基材；（ｂ）該表面に結合された中間層であって、荷電されたポリマー性のリンカーアームを含む中間層；（ｃ）該リンカーアームとの静電相互作用を通じて該中間層に結合された吸着フィルムであって、該吸着フィルムが、該リンカーアームに結合した複数の吸着粒子を含み、該吸着粒子の各々が、結合性官能基を含む、吸着フィルム、を備える、吸着チップ（請求項１）で、前記結合性官能基が生体分子（請求項２９）であるものが知られている（例えば、特許文献１参照。）。しかしながら、特許文献１では、生体分子を検出するものであるが、印刷物ではなく、吸着チップは擦れや削れに対して極めて弱いという問題点がある。 (Prior Art) Conventionally, an adsorption chip comprising the following: (a) a substrate comprising a surface; (b) an intermediate layer bonded to the surface and a charged polymeric linker An intermediate layer comprising arms; (c) an adsorbent film bonded to the intermediate layer through electrostatic interaction with the linker arm, the adsorbing film comprising a plurality of adsorbent particles bonded to the linker arm; It is known that each of the adsorbent particles includes an adsorbing film including an adhering functional group, and an adsorbing chip (Claim 1), wherein the binding functional group is a biomolecule (Claim 29). (For example, refer to Patent Document 1). However, in Patent Document 1, although biomolecules are detected, there is a problem that the adsorption tip, not a printed matter, is extremely vulnerable to rubbing and scraping.
そこで、本発明は上記のような問題点を解消するために、本発明者らは鋭意研究を進め、本発明の完成に至ったものである。その目的は、インキ量も増量せずに、しかも、成分が基材へ染み込んだり、移行したりせず、印刷法でも生体分子の量を確保できて、生体分子の検出においても、非破壊検査を行え、かつ、製造工程中に擦れたり、郵送中やエンドユーザーでの取り扱いなどにより擦れたり、削れたり、かきとられたりせず、生体分子が残存しているので、容易に生体分子を検出することのできる生体分子インキ印刷物の製造方法を提供することである。
In order to solve the above-described problems, the present inventors have made extensive studies and have completed the present invention. Its purpose is not to increase the amount of ink, and the components do not penetrate or migrate to the base material, and the amount of biomolecules can be secured even by printing methods, and non-destructive inspection is also possible in the detection of biomolecules. The biomolecules can be easily detected because they remain in place and are not rubbed, scraped, or scraped during the manufacturing process, during mailing, or handled by the end user. it is to provide a method for producing a biomolecule ink printing product can be.
上記の課題を解決するために、本発明の 請求項１の発明に係わる生体分子インキ印刷物の製造方法は、基材と、該基材の一方の面に目止め層、生体分子印刷層及び保護層をこの順に有し、前記目止め層は紫外線硬化型インキを用い、前記生体分子印刷層は生体分子を含む紫外線硬化型インキを用い、前記保護層は紫外線硬化型インキを用い、前記目止め層、前記生体分子印刷層及び前記保護層は印刷法で印刷された後に紫外線で硬化されたものであり、前記目止め層は前記生体分子印刷層の絵柄より大きく印刷されたものであり、前記保護層は前記生体分子印刷層を覆って該生体分子印刷層の絵柄より大きく印刷されたものである生体分子インキ印刷物の製造方法であって、（１）前記生体分子を脂質で修飾し溶媒に溶解し生体分子希釈液とする工程、（２）前記蛍光色素を溶媒に溶解し蛍光色素希釈液とする工程、（３）前記生体分子希釈液と前記蛍光色素希釈液とを紫外線硬化型インキへ混合し生体分子インキとする工程、（４）前記生体分子インキの蛍光を確認する確認工程、（５）前記基材へ紫外線硬化型インキを用いて、印刷し紫外線で硬化して前記目止め層とする工程、（６）蛍光が確認された前記生体分子インキを用いて、前記目止め層面へ印刷し紫外線で硬化して前記生体分子印刷層とする工程、（７）該生体分子印刷層面へ、保護層インキを印刷し紫外線で硬化して前記保護層とする工程、を有することを特徴とする生体分子インキ印刷物の製造方法である。
In order to solve the above problems, a method for producing a biomolecule ink printed matter according to the invention of claim 1 of the present invention includes a base material, a sealing layer, a biomolecule print layer, and a protection layer on one surface of the base material. Layers in this order, the sealing layer using UV curable ink, the biomolecule printing layer using UV curable ink containing biomolecules, the protective layer using UV curable ink, and the sealing layer, the biomolecule printed layer and the protective layer has been cured with ultraviolet light after being printed by the printing method, the eye stop layer has been printed larger than the pattern of the biomolecule printing layer, the A protective layer is a method for producing a biomolecule ink print that covers the biomolecule printed layer and is printed larger than the pattern of the biomolecule printed layer , and (1) modifies the biomolecule with a lipid and uses it as a solvent. Dissolved biomolecule diluent (2) a step of dissolving the fluorescent dye in a solvent to obtain a fluorescent dye dilution, and (3) mixing the biomolecule dilution and the fluorescent dye dilution into an ultraviolet curable ink to obtain a biomolecule ink. A step, (4) a confirmation step of confirming fluorescence of the biomolecule ink, (5) a step of printing on the base material using an ultraviolet curable ink and curing with ultraviolet rays to form the sealing layer, (6) (7) printing the protective layer ink on the biomolecule printed layer surface, printing on the sealing layer surface using the biomolecule ink whose fluorescence has been confirmed, and curing with ultraviolet rays to form the biomolecule printed layer; the step of said protective layer and cured by ultraviolet rays, a method for producing a biomolecule ink printed material characterized by having a.
請求項１の本発明によれば、製造が容易で、かつ生体分子印刷層に所望量の生体分子が含まれ、郵送中やエンドユーザーでの取り扱いなどでも擦れたり、削れたり、かきとられたりせず、生体分子印刷層に生体分子が残存しているので、生体分子インキ印刷物から容易に生体分子を検出できるという生体分子インキ印刷物の製造方法を提供する。
According to the present invention of claim 1, manufacturing is easy, and contains a desired amount of biomolecules to biomolecules printing layer, or even rubbing etc. handling by mail in and end-users, or scraping, scraped Therefore, the present invention provides a method for producing a biomolecule ink printed material, in which biomolecules remain in the biomolecule printed layer, so that the biomolecule can be easily detected from the biomolecule ink printed material.
以下、本発明の実施形態について、図面を参照しながら、詳細に説明する。 Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings.
（生体分子インキ印刷物）生体分子インキ印刷物１０は、図１に示すように、基材１１と、該基材１１の一方の面に目止め層１３、生体分子印刷層１５及び保護層１７をこの順に有し、前記目止め層１３は紫外線硬化型インキを用い、前記生体分子印刷層１５は生体分子を含む紫外線硬化型インキが硬化した層からなり、前記保護層１７は紫外線硬化型インキが硬化した層からなり、前記目止め層１３は前記生体分子印刷層１５の絵柄より大きく印刷され、前記保護層１７は前記生体分子印刷層１５を覆って該生体分子印刷層１５の絵柄より大きく印刷されていることを特徴とする生体分子インキ印刷物１０である。
(Biomolecules ink prints) BIOLOGICAL molecular ink prints 10, as shown in FIG. 1, a substrate 11, the sealing layer 13 on one surface of the substrate 11, the biomolecule printing layer 15 and protective layer 17 has in this order, the eye stop layer 13 using an ultraviolet curable ink, the biomolecule printing layer 15 is a layer ultraviolet curable ink is cured containing biomolecules, the protective layer 17 is UV-curable ink consists cured layer, before Symbol th stop layer 13 is printed larger than the pattern of the biomolecule printing layer 15, the protective layer 17 is larger than the pattern of the biomolecule printing layer 15 covering the biomolecule printed layer 15 It is the biomolecule ink printed matter 10 characterized by being printed.
（基材）基材１１としては印刷に耐える機械的強度などがあれば特に限定されるものではなく、例えば、プラスチック、紙、金属、ガラスなどの単独又は複合体でもよい。用途に応じて種々の材料が適用でき、例えば、プラスチックであればポリエチレンテレフタレートなどのポリエステル系樹脂、ポリアミド系樹脂、ポリオレフィン系樹脂、（メタ）アクリル系樹脂、セルロース系フィルム、ポリカーボネート系樹脂などが、紙であれば上質紙、コート紙、アート紙、ＮＩＰ紙などが、金属であればアルミニウム、スズなどの、箔、フィルム又はシートのものが適用できる。 (Substrate) The substrate 11 is not particularly limited as long as it has a mechanical strength capable of withstanding printing. For example, it may be a single material or a composite material such as plastic, paper, metal, and glass. Various materials can be applied depending on the application. For example, if plastic, polyester resin such as polyethylene terephthalate, polyamide resin, polyolefin resin, (meth) acrylic resin, cellulose film, polycarbonate resin, For paper, high-quality paper, coated paper, art paper, NIP paper, etc. can be used, and for metal, aluminum, tin, etc., foil, film or sheet can be applied.
基材１１の厚さは、特に限定されるものではないが、通常、１２μｍ〜３ｍｍ程度が適用できるが、５０μｍ〜１ｍｍの範囲内が取扱性の点で好ましい。また、基材１１には必要に応じて、例えば、滑剤、可塑剤、充填剤、帯電防止剤、アンチブロッキング剤等の添加剤を使用してもよい。 Although the thickness of the base material 11 is not specifically limited, Usually, about 12 micrometers-3 mm can be applied, but the inside of the range of 50 micrometers-1 mm is preferable at the point of handleability. Moreover, you may use additives, such as a lubricant, a plasticizer, a filler, an antistatic agent, an antiblocking agent, for example for the base material 11 as needed.
（易接着処理）基材１１には、印刷に先立って、コロナ放電処理、プラズマ処理、プライマ（アンカーコート、接着促進剤、易接着剤とも呼ばれる）などの易接着処理を行ってもよい。必要に応じて設けるプライマ層としては、例えば、塩化ビニル酢酸ビニル共重合体などの酢酸ビニル系樹脂、（メタ）アクリル酸系樹脂、ウレタン系樹脂、ポリエステル系樹脂などの熱可塑性樹脂及びこれらの混合物等が使用され、また、例えばポリウレタン系樹脂、ポリエステル系樹脂、シリコーン系樹脂、アクリル系樹脂や、これらの（ジ）（ポリ）イソシアネートの混合物からなる熱硬化性樹脂、反応型樹脂でもよい。 (Easy Adhesion Treatment) Prior to printing, the substrate 11 may be subjected to an easy adhesion treatment such as a corona discharge treatment, a plasma treatment, and a primer (also called an anchor coat, an adhesion promoter, or an easy adhesive). Examples of the primer layer provided as necessary include vinyl acetate resins such as vinyl chloride vinyl acetate copolymers, thermoplastic resins such as (meth) acrylic acid resins, urethane resins, polyester resins, and mixtures thereof. Further, for example, a polyurethane resin, a polyester resin, a silicone resin, an acrylic resin, a thermosetting resin made of a mixture of these (di) (poly) isocyanates, or a reactive resin may be used.
（目止め層）基材１１に設ける目止め層１３は、紫外線硬化型インキを用いて、印刷法で印刷した後に紫外線で硬化すればよい。目止め層１３は生体分子印刷層１５の絵柄より大きく印刷することで、生体分子印刷層１５中の成分が基材１１へ染み込んだり、印刷後でも、所謂ブリードアウト現象で層の表面へ移行し、これがさらに基材１１へ浸透や移行を防止する。 (Sealing layer) The sealing layer 13 provided on the substrate 11 may be cured with ultraviolet light after printing by a printing method using ultraviolet curable ink. The sealing layer 13 is printed larger than the pattern of the biomolecule printing layer 15, so that the components in the biomolecule printing layer 15 soak into the base material 11, or even after printing, transfer to the surface of the layer by a so-called bleedout phenomenon. This further prevents penetration and migration into the substrate 11.
（目止め層の効果）生体分子印刷層１５中の成分、特に生体分子が減少又は消失してしまうと、生体分子を検出する装置で検出することができなくなる。また、基材１１へ染み込んでしまった生体分子は、基材１１を含めた破壊検査をしないと含有している生体分子が確認できない。さらに、目止め層１３を設けない場合には、染み込み分を補うために生体分子印刷層１５の量を多くする必要があり、生体分子の量を増量したり、インキへの含有量を増加させたり、印刷時にも多色刷りしたりするという欠点がある。また、増量インキを用いると、インキを硬化させるために、紫外線の照射量も増加させねばならないという欠点も併発する。目止め層１３によって、生体分子印刷層１５中の生体分子が基材１１へ染み込まないで、所望の量が確保できていれば、生体分子検出装置での検出の際にも、生体分子印刷層１５を非破壊検査で行え、印刷時の生体分子インキ１４のインキ盛量も少なくすることができる。 (Effect of the sealing layer) When the components in the biomolecule printing layer 15, particularly the biomolecules, are reduced or disappeared, they cannot be detected by a device that detects biomolecules. In addition, biomolecules that have penetrated into the base material 11 cannot be confirmed unless a destructive inspection including the base material 11 is performed. Further, when the sealing layer 13 is not provided, it is necessary to increase the amount of the biomolecule printing layer 15 to compensate for the penetration, and the amount of the biomolecule can be increased or the content in the ink can be increased. Or a multicolor printing at the time of printing. In addition, when an increased amount of ink is used, in order to cure the ink, there is a disadvantage that the irradiation amount of ultraviolet rays must be increased. If the biomolecule in the biomolecule printing layer 15 does not permeate into the base material 11 by the sealing layer 13 and a desired amount can be secured, the biomolecule printing layer can be used for detection by the biomolecule detection apparatus. 15 can be performed by nondestructive inspection, and the amount of ink piled up by the biomolecular ink 14 at the time of printing can also be reduced.
基材１１としては紙やポリオレフィン系樹脂を用いた場合には顕著であり、特に紙類を用いると、印刷時に染み込みが多く、生体分子印刷層１５に留まる生体分子が減少してしまう。また、ポリオレフィン系樹脂などの非晶部を多く含む樹脂を用いると、印刷時はよいものの、印刷後に生体分子が所謂ブリードアウト現象で層の表面へ移行し、これがさらに樹脂へ移行して、生体分子印刷層１５に留まる生体分子が減少してしまう。これらを防止するために、目止め層１３を設ける必要があり、移行防止には硬化によって網目状化、高密度化する紫外線硬化型インキを硬化させた樹脂系が染み込み及び移行を防止する点で好ましい。 This is remarkable when paper or polyolefin resin is used as the base material 11, and particularly when paper is used, there are many penetrations during printing, and biomolecules remaining on the biomolecule printing layer 15 are reduced. In addition, when a resin containing a large amount of amorphous parts such as polyolefin resin is used, the biomolecules migrate to the surface of the layer by the so-called bleed-out phenomenon after printing, which further migrates to the resin, Biomolecules that remain in the molecular print layer 15 are reduced. In order to prevent these, it is necessary to provide the sealing layer 13, and in order to prevent migration, a resin system obtained by curing a UV-curable ink that is reticulated and densified by curing prevents penetration and migration. preferable.
（紫外線硬化型インキ）紫外線硬化型インキの組成物（前駆体ともいう）への紫外線の照射によって重合（硬化ともいう）反応する少なくとも１つの、官能基を有する硬化性成分を含有するもので、該硬化性成分としては、ラジカル重合性不飽和二重結合を有する化合物が適用でき、１官能モノマー、２官能以上の多官能モノマー、官能オリゴマー、官能ポリマーなどがある。また、電離放射線で重合（硬化ともいう）する官能基としては、アクリロイル基、メタクリロイル基、アリル基、またはエポキシ基である。具体的には、ＵＶ ＮＶＲメジューム（Ｔ＆Ｋ ＴＯＫＡ社製、商品名）、ＵＶ ＢＦＳＧメジューム（ＤＩＣＧ社製、商品名）、ダイキュアアビリオＯＰニス（ＤＩＣＧ社製、商品名）などが例示できる。 (Ultraviolet curable ink) It contains at least one curable component having a functional group that reacts by polymerization (also referred to as curing) by irradiation of ultraviolet rays to the composition (also referred to as precursor) of the ultraviolet curable ink, As the curable component, a compound having a radical polymerizable unsaturated double bond can be applied, and examples thereof include a monofunctional monomer, a bifunctional or higher polyfunctional monomer, a functional oligomer, and a functional polymer. The functional group that is polymerized (also called cured) by ionizing radiation is an acryloyl group, a methacryloyl group, an allyl group, or an epoxy group. Specific examples include UV NVR medium (trade name, manufactured by T & K TOKA), UV BFSG medium (trade name, manufactured by DICG), Dicure Avirio OP Varnish (trade name, manufactured by DICG), and the like.
（生体分子印刷層）生体分子印刷層１５は生体分子を含む紫外線硬化型インキを用いて、印刷法で印刷した後に紫外線で硬化すればよい。生体分子印刷層１５の紫外線硬化型インキとしては、目止め層１３に用いる紫外線硬化型インキと同様なものを使用すればよい。 (Biomolecule Print Layer) The biomolecule print layer 15 may be cured by ultraviolet rays after being printed by a printing method using an ultraviolet curable ink containing biomolecules. As the ultraviolet curable ink for the biomolecule printing layer 15, the same ultraviolet curable ink as that used for the sealing layer 13 may be used.
（生体分子）生体分子は生体有機分子とも呼称され、生存生物によって作り出される有機分子であり、例えば、細胞、ウィルス、細菌、胞子、微生物、ヌクレオチド、アミノ酸、ポリペプチド、ペプチド、ペプチドフラグメント、レクチン、タンパク質、ステロイド、核酸、デオキシリボ核酸（ディ・エヌ・エー）、糖、脂肪酸、炭水化物、脂質、薬剤、抗原、抗体、酵素、毒素、有機ポリマーなど、及びこれらの組み合わせ分子が例示できる。 個人認証の用途に用いる生体分子としては、生物学的供給源である体液、例えば、血液、血清、唾液、尿、精液、精漿、リンパなどに由来するものが好適である。生体分子印刷層１５の絵柄は、例えば、矩形や丸などの幾何学模様、文字や数字などの文字、イラストや図柄などでもよく、特に限定されるものではない。
(Biomolecules) Biomolecules are also called organic organic molecules, and are organic molecules created by living organisms, such as cells, viruses, bacteria, spores, microorganisms, nucleotides, amino acids, polypeptides, peptides, peptide fragments, lectins , protein, steroid, nucleic acids, deoxyribonucleic acid (di N. er), sugars, fatty acids, carbohydrates, lipids, drugs, antigens, antibodies, enzymes, toxins, organic polymers, and it can be exemplified combinations molecules. As biomolecules used for personal authentication, those derived from biological fluids that are biological sources, such as blood, serum, saliva, urine, semen, seminal plasma, and lymph are suitable. The pattern of the biomolecule printing layer 15 may be, for example, a geometric pattern such as a rectangle or a circle, a character such as a letter or a number, an illustration or a pattern, and is not particularly limited.
（保護層）保護層１７は紫外線硬化型インキを用いて、印刷法で印刷した後に紫外線で硬化する。保護層１７の紫外線硬化型インキとしては、生体分子印刷層１５に用いる紫外線硬化型インキと同様なものを使用すればよい。 (Protective layer) The protective layer 17 is cured by ultraviolet rays after printing by a printing method using ultraviolet curable ink. As the ultraviolet curable ink for the protective layer 17, the same ultraviolet curable ink as that used for the biomolecule printing layer 15 may be used.
この際に、保護層１７を生体分子印刷層１５を覆って、しかも生体分子印刷層１５の絵柄より大きく印刷することで、生体分子印刷層１５を端部まで覆うことで、製造工程中の擦れ、郵送中やエンドユーザーでの取り扱いなどでも、生体分子インキ印刷物１０の生体分子印刷層１５であるインキ層が擦れたり、削れたり、かきとられたりすることを防止する。その結果、生体分子が減少又は無くなることがなく、生体分子を容易に確実に検出することができる。生体分子の検出によって、生体分子の元の持ち主を特定できるのである。 At this time, the protective layer 17 covers the biomolecule printing layer 15 and is printed larger than the pattern of the biomolecule printing layer 15, thereby covering the biomolecule printing layer 15 to the end, thereby rubbing during the manufacturing process. The ink layer which is the biomolecule printing layer 15 of the biomolecule ink printed product 10 is prevented from being rubbed, scraped or scraped even during mailing or handling by an end user. As a result, the biomolecule can be easily and reliably detected without decreasing or disappearing. By detecting a biomolecule, the original owner of the biomolecule can be identified.
（印刷法）生体分子印刷層１５及び保護層１７の印刷法としては、オフセット印刷や、スクリーン印刷などが適用できるが、自由な絵柄が選択でき、安価なオフセット印刷法が好適である。このように、印刷した後に紫外線で硬化すればよい。いずれの場合も、保護層１７は生体分子印刷層１５を覆って生体分子印刷層１５の絵柄より大きく印刷すればよい。また、目止め層１３、生体分子印刷層１５及び保護層１７は透明でも着色でもよいが、保護層１７は目止め層１３及び生体分子印刷層１５を目視で確認できるので、透明が好ましい。 (Printing method) As the printing method of the biomolecule printing layer 15 and the protective layer 17, offset printing, screen printing, or the like can be applied. However, an inexpensive offset printing method is preferable because a free pattern can be selected. In this way, after printing, it may be cured with ultraviolet rays. In any case, the protective layer 17 may be printed larger than the pattern of the biomolecule printing layer 15 so as to cover the biomolecule printing layer 15. The sealing layer 13, the biomolecule printing layer 15 and the protective layer 17 may be transparent or colored, but the protective layer 17 is preferably transparent because the sealing layer 13 and the biomolecule printing layer 15 can be visually confirmed.
（紫外線）紫外線硬化型インキを硬化させる紫外線装置（ＵＶランプともいう）としては、化学反応用ケミカルランプ、低圧水銀ランプ、高圧水銀ランプ、メタルハライドランプ、可視光ハロゲンランプ等が使用される。ＵＶの照射量としては、２００〜６００ｎｍの波長の積算エネルギーが０．０１〜１０Ｊ／平方センチメートルとなる程度とすることが好ましい。また、ＵＶの照射雰囲気としては、空気中でもよいし、窒素やアルゴン等の不活性ガス雰囲気下でもよい。紫外線硬化型インキの印刷後の照射量は、組成物の材質や量に応じて波長を選択し、ＵＶランプの出力と、加工速度に応じて照射すれば良い。 As an ultraviolet device (also referred to as a UV lamp) that cures (ultraviolet) ultraviolet curable ink, a chemical reaction chemical lamp, a low-pressure mercury lamp, a high-pressure mercury lamp, a metal halide lamp, a visible light halogen lamp, or the like is used. The amount of UV irradiation is preferably such that the integrated energy at a wavelength of 200 to 600 nm is 0.01 to 10 J / square centimeter. The UV irradiation atmosphere may be air or an inert gas atmosphere such as nitrogen or argon. The irradiation amount after the printing of the ultraviolet curable ink may be selected according to the material and amount of the composition, and irradiated according to the output of the UV lamp and the processing speed.
（生体分子インキ印刷物の製造方法）請求項１の発明に係わる生体分子インキ印刷物１０の製造方法は、基材と、該基材の一方の面に目止め層、生体分子印刷層及び保護層をこの順に有し、前記目止め層は紫外線硬化型インキを用い、前記生体分子印刷層は生体分子を含む紫外線硬化型インキを用い、前記保護層は紫外線硬化型インキを用い、前記目止め層、前記生体分子印刷層及び前記保護層は印刷法で印刷された後に紫外線で硬化されたものであり、前記目止め層は前記生体分子印刷層の絵柄より大きく印刷されたものであり、前記保護層は前記生体分子印刷層を覆って該生体分子印刷層の絵柄より大きく印刷されたものである生体分子インキ印刷物の製造方法であって、（１）前記生体分子を脂質で修飾し溶媒に溶解し生体分子希釈液とする工程、（２）前記蛍光色素を溶媒に溶解し蛍光色素希釈液とする工程、（３）前記生体分子希釈液と前記蛍光色素希釈液とを紫外線硬化型インキへ混合し生体分子インキとする工程、（４）前記生体分子インキの蛍光を確認する確認工程、（５）前記基材へ紫外線硬化型インキを用いて、印刷し紫外線で硬化して前記目止め層とする工程、（６）蛍光が確認された前記生体分子インキを用いて、前記目止め層面へ印刷し紫外線で硬化して前記生体分子印刷層とする工程、（７）該生体分子印刷層面へ、保護層インキを印刷し紫外線で硬化して前記保護層とする工程、を有することを特徴とする生体分子インキ印刷物の製造方法である。
(Manufacturing method of biomolecule ink printed matter) The manufacturing method of the biomolecule ink printed matter 10 according to the invention of claim 1 includes a base material, a sealing layer, a biomolecule printing layer and a protective layer on one surface of the base material. In this order, the sealing layer uses an ultraviolet curable ink, the biomolecule printing layer uses an ultraviolet curable ink containing a biomolecule, the protective layer uses an ultraviolet curable ink, the sealing layer, The biomolecule printed layer and the protective layer are printed by a printing method and then cured by ultraviolet rays , and the sealing layer is printed larger than a picture of the biomolecule printed layer , and the protective layer Is a method for producing a biomolecule ink print that covers the biomolecule print layer and is printed larger than the pattern of the biomolecule print layer , and (1) modifies the biomolecule with lipid and dissolves it in a solvent. Biomolecule diluent (2) a step of dissolving the fluorescent dye in a solvent to form a fluorescent dye dilution, and (3) mixing the biomolecule dilution and the fluorescent dye dilution into an ultraviolet curable ink, (4) a confirmation step for confirming the fluorescence of the biomolecule ink, (5) a step of printing on the substrate using an ultraviolet curable ink and curing with ultraviolet rays to form the sealing layer, (6) ) A step of printing on the surface of the sealing layer using the biomolecule ink that has been confirmed to be fluorescent and curing with ultraviolet light to form the biomolecule printed layer; (7) printing a protective layer ink on the surface of the biomolecule printed layer; a method for producing a biomolecule ink prints, characterized in that by a step, to the protective layer was cured by ultraviolet light.
（第一工程）（１）前記生体分子を脂質で修飾し溶媒に溶解し生体分子希釈液とする工程である。まず、生体分子をアルコール系、石油系、乾性油などの溶媒に溶解させて、生体分子希釈液とする。しかしながら、溶解しにくい場合には、予め生体分子を脂質で修飾しておくことが好ましい。溶媒の具体例としては、ＵＶ ＤＧレジューサー（Ｔ＆Ｋ ＴＯＫＡ社製）、ＵＶ ＢＦレジューサー（ＤＩＣＧ社製）などが例示できる。 (First Step) (1) This is a step in which the biomolecule is modified with lipid and dissolved in a solvent to obtain a biomolecule dilution. First, a biomolecule is dissolved in a solvent such as alcohol, petroleum, or dry oil to obtain a biomolecule dilution. However, when it is difficult to dissolve, it is preferable to previously modify the biomolecule with lipid. Specific examples of the solvent include a UV DG reducer (manufactured by T & K TOKA) and a UV BF reducer (manufactured by DICG).
（第二工程）（２）前記蛍光色素を溶媒に溶解し蛍光色素希釈液とする工程である。蛍光色素をアルコール系、石油系、乾性油などの溶媒に溶解させて、蛍光色素希釈液とする。蛍光色素としては、上記の溶媒に易溶なフルオレセイン系蛍光色素、クマリン系蛍光色素、ローダミン系蛍光色素などが好ましい。 (Second step) (2) In this step, the fluorescent dye is dissolved in a solvent to obtain a fluorescent dye dilution. A fluorescent dye is dissolved in a solvent such as alcohol, petroleum or drying oil to obtain a fluorescent dye dilution. As the fluorescent dye, a fluorescein fluorescent dye, a coumarin fluorescent dye, a rhodamine fluorescent dye and the like which are easily soluble in the above-mentioned solvent are preferable.
（第三工程）（３）前記生体分子希釈液と前記蛍光色素希釈液とを紫外線硬化型インキへ混合し生体分子インキ１４とする工程である。前述の第一工程で作成した生体分子希釈液、及び前述の第二工程で作成した蛍光色素希釈液とを、紫外線硬化型インキへ混合して生体分子インキ１４とする。混合する方法としては特に限定はなく、通常の混練分散機、例えば、三本ロールミル、アトライター、高速インペラー分散機、デスパー、高速ミキサー、タンブラー、ブレンダーなどが適用できる。 (Third step) (3) In this step, the biomolecule diluent and the fluorescent dye diluent are mixed with ultraviolet curable ink to form biomolecule ink 14. The biomolecule diluent prepared in the first step described above and the fluorescent dye diluent prepared in the second step described above are mixed into the ultraviolet curable ink to obtain biomolecule ink. The mixing method is not particularly limited, and an ordinary kneading and dispersing machine such as a three-roll mill, an attritor, a high-speed impeller disperser, a desper, a high-speed mixer, a tumbler, and a blender can be applied.
なお、蛍光色素は生体分子への混合によって、生体分子へ結合又は吸着されるが、生体分子の安定性のために化学結合が好ましい。生体分子インキ１４については、この蛍光色素にムラがないことで、生体分子が生体分子インキ１４中へ均一に分散又は溶解したことが確認できる。 The fluorescent dye is bonded or adsorbed to the biomolecule by mixing with the biomolecule, but chemical bonding is preferable for the stability of the biomolecule. Regarding the biomolecule ink 14, it can be confirmed that the biomolecules are uniformly dispersed or dissolved in the biomolecule ink 14 because the fluorescent dye is not uneven.
（第四工程）（４）前記生体分子インキ１４の蛍光を確認する確認工程である。しかしながら、特に着色された紫外線硬化型インキを用いた場合の印刷時には、生体分子の存在が確認が難しいという問題があった。そこで、蛍光色素の蛍光を確認することで、生体分子の存在を担保できる。印刷前に蛍光発色を確認することで、生体分子印刷層に所望量の生体分子が含まれることを、事前に保証でき、製造後の生体分子インキ印刷物からは、確実に生体分子を検出できる。 (Fourth Step) (4) This is a confirmation step for confirming the fluorescence of the biomolecule ink 14. However, there is a problem in that it is difficult to confirm the presence of biomolecules during printing, particularly when colored ultraviolet curable ink is used. Therefore, the presence of biomolecules can be ensured by confirming the fluorescence of the fluorescent dye. By confirming the fluorescence coloring before printing, it can be ensured in advance that a desired amount of biomolecules are contained in the biomolecule printing layer, and the biomolecules can be reliably detected from the printed biomolecule ink printed matter.
（第五工程）（５）前記基材１１へ紫外線硬化型インキを用いて、印刷し紫外線で硬化して前記目止め層１３とする工程である。目止め層１３は。次工程の生体分子印刷層１５で印刷する絵柄より大きく印刷することで、生体分子印刷層１５が基材１１と直接接触しないようにし、さらに、次々工程の保護層１７とで挟むようにして、生体分子印刷層１５を保護することができる。 (5th process) (5) It is the process of using the ultraviolet curable ink for the said base material 11, printing and hardening | curing with an ultraviolet-ray, and setting it as the said sealing layer 13. FIG. The sealing layer 13 is. By printing larger than the pattern to be printed by the biomolecule printing layer 15 in the next step, the biomolecule printing layer 15 is prevented from coming into direct contact with the base material 11 and further sandwiched between the protective layers 17 in the next step. The printing layer 15 can be protected.
（第六工程）（６）蛍光が確認された前記生体分子インキ１４を用いて、前記目止め層１３面へ印刷し紫外線で硬化して前記生体分子印刷層１５とする工程である。目止め層１３面へ生体分子インキ１４を用いて、印刷し紫外線で硬化して生体分子印刷層１５とする。 (Sixth Step) (6) In this step, the biomolecule ink 14 with confirmed fluorescence is printed on the surface of the sealing layer 13 and cured with ultraviolet rays to form the biomolecule printed layer 15. A biomolecule ink 14 is printed on the surface of the sealing layer 13 and cured with ultraviolet rays to form a biomolecule printed layer 15.
（第七工程）（７）該生体分子印刷層１５面へ、保護層インキを印刷し紫外線で硬化して前記保護層１７とする工程である。前述で印刷した目止め層１３、生体分子印刷層１５面へ、保護層インキを印刷し紫外線で硬化して保護層１７として、生体分子インキ印刷物１０となる。この際には、保護層１７は生体分子印刷層１５を覆って、生体分子印刷層１５の絵柄より大きく印刷することはいうまでもない。 (Seventh step) (7) In this step, the protective layer ink is printed on the surface of the biomolecule printed layer 15 and cured with ultraviolet rays to form the protective layer 17. The protective layer ink is printed on the surface of the sealing layer 13 and the biomolecule printing layer 15 printed as described above and cured with ultraviolet rays to form the biomolecule ink printed matter 10 as the protective layer 17. In this case, it goes without saying that the protective layer 17 covers the biomolecule printing layer 15 and prints larger than the pattern of the biomolecule printing layer 15.
また、目止め層１３、生体分子印刷層１５及び保護層１７への紫外線の照射は各層で行って硬化したが、生体分子印刷層１５と保護層１７の２層を印刷した後に紫外線を照射して全層を一度に硬化させてもよい。なお、目止め層１３への紫外線の照射は印刷後に硬化した方が、生体分子印刷層１５の印刷時に浸透や染み込みを防止できる点で好ましい。 In addition, the sealing layer 13, the biomolecule printing layer 15 and the protective layer 17 were irradiated with ultraviolet rays in each layer and cured, but after the two layers of the biomolecule printing layer 15 and the protective layer 17 were printed, the ultraviolet rays were irradiated. All layers may be cured at once. Note that it is preferable that the sealing layer 13 is irradiated with ultraviolet rays after being printed because it can be prevented from penetrating and permeating when the biomolecule printing layer 15 is printed.
（検出）生体分子印刷層１５に含まれる生体分子は、公知の電気泳動ゲル、又はｃＤＮＡマイクロアレイなどの生体分子を検出する装置、アレイ、キット及び方法によって検出でき、生体分子のパターンが同定される。検出された生体分子からは、生体分子の元の動植物や個人を特定することができる。 (Detection) The biomolecules contained in the biomolecule printing layer 15 can be detected by a known electrophoretic gel or a device, array, kit and method for detecting biomolecules such as a cDNA microarray, and the biomolecule pattern is identified. . From the detected biomolecule, it is possible to identify the original animal or plant or individual of the biomolecule.
以下、実施例及び比較例により、本発明を更に詳細に説明するが、これに限定されるものではない。なお、溶媒を除き、各層の各組成物は固形分換算の質量部である。 EXAMPLES Hereinafter, although an Example and a comparative example demonstrate this invention further in detail, it is not limited to this. In addition, except a solvent, each composition of each layer is a mass part of solid content conversion.
（実施例１）基材１１として、日本製紙製の斤量７０ｋｇのＮＰＩフォーム用紙を用い、生体分子として皮膚細胞からとったディ・エヌ・エーを用いた。
まず、（１）生体分子を脂質で修飾し、溶媒のＵＶ ＳＧレジューサー（ＤＩＣＧ社製）へ溶解し生体分子が１％の生体分子希釈液とした。
（２）生体分子希釈液２０部を紫外線硬化型インキであるＵＶ ＢＦＳＧメジューム（ＤＩＣＧ社製、商品名）８０部へ混合して、生体分子インキ１４とした。
（３）前記基材１１へ紫外線硬化型インキであるＵＶ ＢＦＳＧメジューム（ＤＩＣＧ社製）を用いて、印刷し紫外線で硬化して目止め層１３とした。なお、目止め層１３は次工程の生体分子印刷層１５で印刷する絵柄より大きい直径８ｍｍの円形で印刷した。
（４）前記生体分子インキ１４を用いて、オフセット印刷で、目止め層１３の円形よりはみ出さないように、直径６ｍｍの円形で印刷し、紫外線で硬化して生体分子印刷層１５とした。なお、印刷インキ盛量は、０．１２５立方センチメートルの生体分子インキ１４をＲＩテスターの２分割ローラーを使用して展色した。
（５）該生体分子印刷層１５面へ、印刷インキ盛量として０．１２５立方センチメートルの保護層インキをＲＩテスターの２分割ローラーを使用して展色したオフセット印刷で、生体分子印刷層１５の絵柄より大きく、さらに目止め層１３の円形よりはみ出すように、保護層インキを用いて直径１０ｍｍの円形の絵柄を印刷し紫外線で硬化して保護層１７として、実施例１の生体分子インキ印刷物１０を得た。
Example 1 NPI foam paper with a weight of 70 kg made by Nippon Paper Industries Co., Ltd. was used as the substrate 11 and DNA taken from skin cells as biomolecules.
First, (1) a biomolecule was modified with lipid and dissolved in a solvent, UV SG reducer (manufactured by DICG), to obtain a biomolecule dilution with 1% biomolecule.
(2) A biomolecule ink 14 was prepared by mixing 20 parts of the biomolecule diluted solution with 80 parts of UV BFSG medium (trade name, manufactured by DICG) which is an ultraviolet curable ink.
(3) Using the UV BFSG medium (made by DICG) which is an ultraviolet curable ink, it printed on the said base material 11, and it hardened | cured with the ultraviolet-ray, and it was set as the sealing layer 13. FIG. The sealing layer 13 was printed in a circle having a diameter of 8 mm larger than the pattern printed by the biomolecule printing layer 15 in the next step.
(4) By using the biomolecule ink 14, printing was performed in a circle having a diameter of 6 mm by offset printing so as not to protrude from the circle of the sealing layer 13, and cured with ultraviolet rays to form a biomolecule printed layer 15. In addition, as for the printing ink accumulation amount, 0.125 cubic centimeters of biomolecular ink 14 was developed using a two-part roller of an RI tester.
(5) The pattern of the biomolecule printing layer 15 is formed by offset printing in which a protective layer ink of 0.125 cubic centimeters as a printing ink amount is spread on the surface of the biomolecule printing layer 15 using a two-segment roller of an RI tester. The biomolecule ink printed material 10 of Example 1 was printed as a protective layer 17 by printing a circular pattern having a diameter of 10 mm using a protective layer ink so as to protrude beyond the circular shape of the sealing layer 13 and curing with ultraviolet rays. Obtained.
（実施例２）基材１１、生体分子、インキ盛量は実施例１と同様にした。
まず、（１）生体分子へローダミン系蛍光色素を結合させて蛍光性生体分子とし、該蛍光性生体分子を溶媒のＵＶ ＳＧレジューサー（ＤＩＣＧ社製）へ溶解し、蛍光性生体分子が１％の蛍光性生体分子希釈液とした。
（２）蛍光性生体分子希釈液２０部を紫外線硬化型インキであるＵＶ ＢＦＳＧメジューム（ＤＩＣＧ社製、商品名）８０部へ混合して、蛍光性の生体分子インキ１４とした。
（３）該蛍光性の生体分子インキ１４をブラックライトで照射して、蛍光を確認した後に、
（４）前記基材１１へ紫外線硬化型インキであるＵＶ ＢＦＳＧメジューム（ＤＩＣＧ社製）を用いて、印刷し紫外線で硬化して目止め層１３とした。なお、目止め層１３は次工程の生体分子印刷層１５で印刷する絵柄より大きい直径８ｍｍの円形で印刷した。
（５）前記生体分子インキ１４を用いて、目止め層１３の円形よりはみ出さないように、直径６ｍｍの円形で印刷し紫外線で硬化して生体分子印刷層１５とし、引き続いて、
（６）該生体分子印刷層１５面へ、生体分子印刷層の絵柄より大きく、さらに目止め層１３の円形よりはみ出すように、保護層インキを用いて直径１０ｍｍの円形の絵柄を印刷し紫外線で硬化して保護層１７として、実施例２の生体分子インキ印刷物１０を得た。
(Example 2) The base material 11, biomolecules, and ink volume were the same as in Example 1.
First, (1) a rhodamine-based fluorescent dye is bound to a biomolecule to form a fluorescent biomolecule, and the fluorescent biomolecule is dissolved in a solvent UV SG reducer (manufactured by DICG). This was a fluorescent biomolecule diluent.
(2) Fluorescent biomolecule diluted solution 20 parts was mixed with 80 parts of UV BFSG medium (manufactured by DICG, trade name) which is an ultraviolet curable ink to obtain fluorescent biomolecule ink 14.
(3) After irradiating the fluorescent biomolecule ink 14 with black light and confirming fluorescence,
(4) Using the UV BFSG medium (made by DICG) which is an ultraviolet curable ink, it printed on the said base material 11, and it hardened | cured with the ultraviolet-ray, and it was set as the sealing layer 13. FIG. The sealing layer 13 was printed in a circle having a diameter of 8 mm larger than the pattern printed by the biomolecule printing layer 15 in the next step.
(5) Using the biomolecule ink 14, in order not to protrude from the circular shape of the sealing layer 13, it is printed in a circle with a diameter of 6 mm and cured with ultraviolet rays to form a biomolecule printed layer 15;
(6) A 10 mm diameter circular pattern is printed on the surface of the biomolecule printed layer 15 with a protective layer ink so that it is larger than the pattern of the biomolecule printed layer and protrudes from the circular shape of the sealing layer 13. It cured and the biomolecule ink printed material 10 of Example 2 was obtained as the protective layer 17.
（実施例３）基材１１、生体分子、インキ盛量は実施例１と同様にした。
まず、（１）生体分子を脂質で修飾し、溶媒のＵＶ ＳＧレジューサー（ＤＩＣＧ社製）へ溶解し生体分子が１％の生体分子希釈液とした。
（２）蛍光色素としてフルオレセイン系蛍光色素を用いて、溶媒のＵＶ ＢＦレジューサー（ＤＩＣＧ社製）へ溶解し蛍光色素が０．１％の蛍光色素希釈液とした。
（３）生体分子希釈液２０部と蛍光色素希釈液２０部とを紫外線硬化型インキであるＵＶ ＢＦＳＧメジューム（ＤＩＣＧ社製）６０部へ混合して、生体分子インキ１４とした。
（４）該生体分子インキ１４をブラックライトで照射して、蛍光を確認した後に、
（５）前記基材１１へ紫外線硬化型インキであるＵＶ ＢＦＳＧメジューム（ＤＩＣＧ社製）を用いて、印刷し紫外線で硬化して目止め層１３とした。なお、目止め層１３は次工程の生体分子印刷層１５で印刷する絵柄より大きい直径８ｍｍの円形で印刷した。
（６）前記生体分子インキ１４を用いて、目止め層１３の円形よりはみ出さないように、直径６ｍｍの円形で印刷し紫外線で硬化して生体分子印刷層１５とし、引き続いて、
（７）該生体分子印刷層１５面へ、生体分子印刷層の絵柄より大きく、さらに目止め層１３の円形よりはみ出すように、保護層インキを用いて直径１０ｍｍの円形の絵柄を印刷し紫外線で硬化して保護層１７として、実施例３の生体分子インキ印刷物１０を得た。
(Example 3) The base material 11, the biomolecule, and the ink deposit amount were the same as in Example 1.
First, (1) a biomolecule was modified with lipid and dissolved in a solvent, UV SG reducer (manufactured by DICG), to obtain a biomolecule dilution with 1% biomolecule.
(2) A fluorescein-based fluorescent dye was used as the fluorescent dye, which was dissolved in a solvent, UV BF reducer (manufactured by DICG), to obtain a fluorescent dye dilution solution containing 0.1% fluorescent dye.
(3) A biomolecule ink 14 was prepared by mixing 20 parts of the biomolecule diluent and 20 parts of the fluorescent dye diluent into 60 parts of UV BFSG medium (DICG), which is an ultraviolet curable ink.
(4) After irradiating the biomolecule ink 14 with black light and confirming fluorescence,
(5) Using the UV BFSG medium (made by DICG) which is an ultraviolet curable ink, it printed on the said base material 11, and it hardened | cured with the ultraviolet-ray, and it was set as the sealing layer 13. FIG. The sealing layer 13 was printed in a circle having a diameter of 8 mm larger than the pattern printed by the biomolecule printing layer 15 in the next step.
(6) Using the biomolecule ink 14, in order not to protrude from the circle of the sealing layer 13, it is printed in a circle with a diameter of 6 mm and cured with ultraviolet rays to form a biomolecule printed layer 15,
(7) A 10 mm diameter circular pattern is printed on the surface of the biomolecule printed layer 15 with a protective layer ink so as to be larger than the pattern of the biomolecule printed layer and beyond the circular shape of the sealing layer 13. It cured and the biomolecule ink printed matter 10 of Example 3 was obtained as the protective layer 17.
（評価方法）実施例１〜３の生体分子インキ印刷物１０を用いて、電気泳動ゲル装置で、生体分子印刷層１５に含まれる生体分子が検出でき、さらに生体分子から元の個人を特定することができた。なお、生体分子印刷層１５中含まれた生体分子の量は、基材１１へ移行しておらず、分析するのに充分な量であった。 (Evaluation method) The biomolecule ink printed matter 10 of Examples 1 to 3 can be used to detect biomolecules contained in the biomolecule printed layer 15 with an electrophoresis gel apparatus, and the original individual is identified from the biomolecules. I was able to. Note that the amount of biomolecule contained in the biomolecule printed layer 15 was not transferred to the substrate 11 and was sufficient for analysis.
（産業上の利用可能性）生体分子インキ印刷物１０の用途としては、生物医学分析や、環境科学、獣医学、薬学検索、食品及び水の品質管理、個人認証などの分野が考えられる。しかしながら、生体分子インキ印刷物１０を必要とする用途であれば、特に限定されるものではない。
The use of raw body molecular ink printed matter 10 (Industrial Applicability), biomedical analysis and, environmental science, veterinary medicine, pharmacy search, food and quality management of water, is the field of personal authentication is considered. However, it is not particularly limited as long as it is an application that requires the biomolecule ink print 10.
１０：生体分子インキ印刷物
１１：基材
１３：目止め層
１５：生体分子印刷層
１７：保護層
10: biomolecules ink prints 11: substrate 13: the sealing layer 15: biomolecules child print layer 17: protective layer
Claims (1)
前記目止め層は紫外線硬化型インキを用い、
前記生体分子印刷層は生体分子を含む紫外線硬化型インキを用い、
前記保護層は紫外線硬化型インキを用い、
前記目止め層、前記生体分子印刷層及び前記保護層は印刷法で印刷された後に紫外線で硬化されたものであり、
前記目止め層は前記生体分子印刷層の絵柄より大きく印刷されたものであり、
前記保護層は前記生体分子印刷層を覆って該生体分子印刷層の絵柄より大きく印刷されたものである生体分子インキ印刷物の製造方法であって、
（１）前記生体分子を脂質で修飾し溶媒に溶解し生体分子希釈液とする工程、
（２）前記蛍光色素を溶媒に溶解し蛍光色素希釈液とする工程、
（３）前記生体分子希釈液と前記蛍光色素希釈液とを紫外線硬化型インキへ混合し生体分子インキとする工程、
（４）前記生体分子インキの蛍光を確認する確認工程、
（５）前記基材へ紫外線硬化型インキを用いて、印刷し紫外線で硬化して前記目止め層とする工程、
（６）蛍光が確認された前記生体分子インキを用いて、前記目止め層面へ印刷し紫外線で硬化して前記生体分子印刷層とする工程、
（７）該生体分子印刷層面へ、保護層インキを印刷し紫外線で硬化して前記保護層とする工程、を有することを特徴とする生体分子インキ印刷物の製造方法。
A base material, and a sealing layer, a biomolecule printing layer, and a protective layer in this order on one surface of the base material;
The sealing layer uses an ultraviolet curable ink,
The biomolecule printing layer uses an ultraviolet curable ink containing biomolecules,
The protective layer uses ultraviolet curable ink,
The sealing layer, the biomolecule printing layer and the protective layer are printed by a printing method and then cured with ultraviolet rays .
The eye stop layer has been printed larger than the pattern of the biomolecule printing layer,
The protective layer is a method for producing a biomolecule ink printed matter that covers the biomolecule printed layer and is printed larger than the pattern of the biomolecule printed layer ,
(1) A step of modifying the biomolecule with lipid and dissolving it in a solvent to obtain a biomolecule dilution,
(2) A step of dissolving the fluorescent dye in a solvent to obtain a fluorescent dye diluent,
(3) A step of mixing the biomolecule diluent and the fluorescent dye diluent into an ultraviolet curable ink to form a biomolecule ink,
(4) a confirmation step for confirming fluorescence of the biomolecule ink;
(5) Using the ultraviolet curable ink on the substrate, printing and curing with ultraviolet rays to form the sealing layer,
(6) Using the biomolecule ink in which fluorescence is confirmed, printing on the sealing layer surface and curing with ultraviolet rays to form the biomolecule printed layer;
(7) to the biomolecule printing layer surface, a manufacturing method of biomolecules ink printed material characterized by having a step, to the protective layer of the protective layer ink was cured by printing with ultraviolet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012075484A JP5953873B2 (en) | 2012-03-29 | 2012-03-29 | Method for producing biomolecule printed matter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012075484A JP5953873B2 (en) | 2012-03-29 | 2012-03-29 | Method for producing biomolecule printed matter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013202967A JP2013202967A (en) | 2013-10-07 |
| JP5953873B2 true JP5953873B2 (en) | 2016-07-20 |
Family
ID=49522593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012075484A Active JP5953873B2 (en) | 2012-03-29 | 2012-03-29 | Method for producing biomolecule printed matter |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5953873B2 (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001063300A (en) * | 1999-08-24 | 2001-03-13 | Toppan Printing Co Ltd | Method of preventing forgery of OVD-forming medium and OVD-forming medium with forgery prevention |
| JP4629175B2 (en) * | 1999-12-16 | 2011-02-09 | 日油株式会社 | Monoclonal antibody |
| JP2001327591A (en) * | 2000-03-13 | 2001-11-27 | Shigeo Okahata | Medical or dental material and method for manufacturing the same |
| JP2006150643A (en) * | 2004-11-26 | 2006-06-15 | Dainippon Printing Co Ltd | Perfume ink printed matter |
| JP2006284986A (en) * | 2005-04-01 | 2006-10-19 | Identity Science Kk | Sealing seal and authentication system and authentication method using the sealing seal |
| JP4946104B2 (en) * | 2006-03-15 | 2012-06-06 | 大日本印刷株式会社 | Infrared absorbing ink printed matter |
| JP4378380B2 (en) * | 2006-12-29 | 2009-12-02 | 恒信印刷株式会社 | Printed matter printed with ink containing human, animal or plant DNA |
| JP2011161797A (en) * | 2010-02-10 | 2011-08-25 | Dainippon Printing Co Ltd | Transfer body |
-
2012
- 2012-03-29 JP JP2012075484A patent/JP5953873B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013202967A (en) | 2013-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | Spray‐painted hydrogel coating for marine antifouling | |
| Hossain et al. | Development of a bioactive paper sensor for detection of neurotoxins using piezoelectric inkjet printing of sol− gel-derived bioinks | |
| KR102327723B1 (en) | Double-sided black adhesive tape | |
| KR102156002B1 (en) | Double-sided adhesive tape and method for manufacturing same | |
| US7670686B2 (en) | Long-term hydrophilic modification of PDMS substrate and method for manufacturing the same | |
| Haase et al. | Plasma pre-treatments to improve the weather resistance of polyurethane coatings on black spruce wood | |
| KR20170139600A (en) | A photocurable resin composition, a process for producing a cured film using the same, and a laminate including the cured film | |
| TWI777184B (en) | Thin-film laminate with printed layer, optical laminate including the thin-film laminate with printed layer, and image display device using the same | |
| JP5970912B2 (en) | Method for producing biomolecule printed matter | |
| JP5953873B2 (en) | Method for producing biomolecule printed matter | |
| JP5966660B2 (en) | Method for producing biomolecular ink composition | |
| CN1712967A (en) | A silicon rubber microfluidic chip coated with polyvinyl alcohol and its surface modification method | |
| JP2013244611A (en) | Biomolecule ink printed matter, and manufacturing method therefor | |
| JP2016052799A (en) | Printed biomolecule and method for producing the same | |
| CN106068315B (en) | Double-sided black tape | |
| JP2004345228A (en) | Hard coat transfer material, method for producing the same, and hard coat body | |
| JP2000288381A (en) | Manufacture of microchemical device | |
| Luo et al. | Printable Hydrogel Arrays for Portable and High-Throughput Shear-Mediated Assays | |
| JP2018079617A (en) | Coating film with fine uneven structure on the surface | |
| JP6759407B2 (en) | Polymer plastic front panel and its manufacturing method | |
| JP2021059112A (en) | Print layer-provided film layered body, optical layered body including that print layer-provided film layered body, and image display device using them | |
| US20160362781A1 (en) | Method of modifying substrate surface | |
| KR20170085628A (en) | Visible light curing transparent resin composition for SLA type 3D printing and preparation method thereof | |
| KR102862988B1 (en) | Method for manufacturing a laminated film with a printed layer attachment | |
| Gržan et al. | UV irradiation of wood surface: bonding properties |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7421 Effective date: 20130809 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150129 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160309 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160311 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160422 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160517 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160530 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5953873 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |